DRUG DESIGNATION: Pfizer says U.S. regulators have classified its experimental pill for advanced, often-deadly breast cancer as a breakthrough therapy. That's done to speed up development and review of treatments seen as big advances.
THE RESEARCH: Palbociclib is in late-stage testing as an initial treatment for the biggest subgroup of postmenopausal women with advanced breast cancer — those in whom tumor growth is fueled by the hormone estrogen but not by a growth-promoting protein called HER2.
MORE TESTING: Pfizer, which has made research on cancer medicines a priority, also is testing palbociclib as a treatment for other cancers.
Rush Limbaugh defends Rubio’s debate answer: He’s absolutely right that Obama knows what he’s doing
Rush Limbaugh Blasts Chris Christie, Says Rubio Was RIGHT About Obama | RedState
- What Is Your U.S. Income Percentile Ranking?
"Why Not Just Shoot Him In The Leg?"
Toxic Words | Human Events
Rob Lowe catches heat for comments about Cam Newton's post #SB50 press conference
After Getting Police Escort, Beyonce Spews Black Lives Matter Message at Super Bowl